Nachrichten zur Pfizer Inc. Aktie

Pfizer Could Be The Turnaround Story In The Pharmaceutical Space

…

Pfizer (PFE) Surpasses Market Returns: Some Facts Worth Knowing

In the closing of the recent trading day, Pfizer (PFE) stood at $24.31, denoting a +1.17% move from the preceding…

Pfizer to Face Several Headwinds: Can It Successfully Navigate Them?

PFE faces a decline in COVID revenues, LOE pressure and IRA impacts but rising EPS estimates offer a glimmer of…

My 5 Favorite Dirt Cheap Stocks to Buy Right Now

Though indexes have rebounded, the first half of the year has been rocky for investors. The market had to digest…

10 Stocks That Pay $100 or More in Dividends

Looking for stocks that pay $100 in annual income? Youve come to the right place. Even a small investment in…

Beyond Air (XAIR) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool. DATETuesday, June 17, 2025, at 4:30 p.m. EDTCALL PARTICIPANTSChairman and Chief Executive Officer — Steven Adam…

Pfizer vs BMY: Which Oncology Drugmaker Is a Better Choice for Now?

Pfizers broader portfolio and higher dividend yield give it an edge over Bristol Myers in the oncology showdown.…

Pfizer: An Offensive Play For A Bear Market

…

2 Top Stocks to Buy With Less Than $30

Though wealthy and successful investors garner much attention on Wall Street, equity markets are accessible to the average person. Thats…

Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trumps plan

The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating billions…

Targeted cancer drugs may replace chemo for some patients — and drugmakers say theyre getting closer

Companies like AstraZeneca, Daiichi Sankyo, Pfizer and Merck are learning from previous setbacks in the ADC space to improve their…

Pfizer, AbbVie und Co unter Druck: Trump mit dem nächsten Hammer?

US-Präsident Donald Trump will der Pharma-Industrie weiter an den Kragen gehen. Laut Kreisen möchte der Republikaner die Pharmawerbung in den…

Pfizer, AbbVie und Co unter Druck: Trump mit dem nächsten Hammer?

US-Präsident Donald Trump will der Pharma-Industrie weiter an den Kragen gehen. Laut Kreisen möchte der Republikaner die Pharmawerbung in den…

Why I Just Bought More of This Beaten-Down 7%-Yielding Dividend Stock

Pick a time frame -- year to date, last 12 months, last three years, last five years, or last 10…

5 Large Drug Stocks That Are Poised to Ride on Sector Recovery

In the Large-Cap Pharmaceuticals industry, AbbVie, Novartis, Pfizer, Sanofi and Bayer are worth retaining amid macro pressure and rising innovation.…

Warren Buffett Says Buy This Index Fund, and Heres How It Could Turn $500 Per Month Into $1 Million

Warren Buffett is the CEO of the Berkshire Hathaway holding company, where he oversees a number of wholly owned subsidiaries…

UBS belässt Pfizer auf Neutral - Ziel 25 Dollar

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Pfizer nach einem Investorengespräch auf "Neutral" mit einem…

Why Apple, Microsoft, Pfizer and other U.S. multinational corporations set up shop in Ireland

U.S. firms remain attracted to Irelands strong business environment built on favorable tax treatment of intellectual property.…

Create a Portfolio of Passive Income: 3 High-Yielding Dividend Stocks That Pay More Than 5%

Dividend income offers a great way to strengthen your overall financial position. It can potentially make you less dependent on…

Top Cancer Stocks to Supercharge Your 2025 Portfolio

Pfizer, Novartis and Fate Therapeutics are making bold oncology moves as demand surges for next-gen cancer therapies.…

Moderna, Pfizer, and BioNTech stocks dip on vaccine panel overhaul By Investing.com

Moderna, Pfizer, and BioNTech stocks dip on vaccine panel overhaul…

Pfizer Inc. (PFE) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

…

Pfizer Stock Down Almost 11% YTD: Should You Buy the Dip?

PFE lags the market as COVID sales drop and patent losses loom, but new drugs and cost cuts may fuel…

Pfizer CEO says no commitments made in meetings with US governments on drug pricing

Pfizer and other drug companies have met with the Trump administration to discuss most-favored-nation pricing but no commitments have been…

3 Stocks With Mouthwatering Dividends You Can Buy Right Now

How would you like to get paid every quarter (and sometimes every month) to own a stock? Thats exactly what…

Should You Buy Pfizer Stock Right Now?

If you have an opening in your portfolio for a great stock with solid growth potential and perhaps even a…

Better High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologis @themotleyfool #stocks $PLD $PFE $AMZN $FDX $HD $MCO $SPGI $BMY $BBIO

…

Better High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologis

Investors looking for sources of passive income to fuel their retirement dreams face a dilemma. Should you chase high yields…

Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer

StoneCo, Centene, CVS, and Pfizer stand out as top value picks with strong cash flow amid market uncertainty.…

Pfizer Market-Perform

NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Pfizer mit einem Kursziel von 30 US-Dollar…

Bernstein belässt Pfizer auf Market-Perform - Ziel 30 Dollar

NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Pfizer mit einem Kursziel von 30 US-Dollar…

Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO

Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, Medicare patients.…

Pfizer: I Should Have Sold Earlier (Downgrade)

…

Pfizers R&D Optimization Delivers Great Results & Secure Dividends

…

Pfizer Neutral

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer anlässlich der Asco-Krebsforschertagung mit einem Kursziel von…

JPMorgan belässt Pfizer auf Neutral - Ziel 30 Dollar

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer anlässlich der Asco-Krebsforschertagung mit einem Kursziel von…

Addiction Disorders Drugs Market Analysis and Forecast to 2030: A $39.5 Billion Opportunity Led by Pfizer, Johnson & Johnson, and Indivior

Dublin, June 02, 2025 (GLOBE NEWSWIRE) -- The "Addiction Disorders Drugs Market by Indication, Product Type, Route of…

Terrible News for Pfizer Stock Investors

The past three years have been challenging for Pfizer (NYSE: PFE). Revenue and earnings have moved in the wrong direction,…

Arvinas and Pfizers Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer

NEW HAVEN, Conn. and NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE:…

Pfizer (PFE) Down 5% Since Last Earnings Report: Can It Rebound?

Pfizer (PFE) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…

Pfizer Hold

HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Pfizer von 28 auf 25 US-Dollar gesenkt und die…

Berenberg senkt Ziel für Pfizer auf 25 Dollar - Hold

HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Pfizer von 28 auf 25 US-Dollar gesenkt und die…

Unlocking Pfizers Value: Cost Controls And Oncology Pipeline

…

Is Pfizer Stock a Buy After This $1.25 Billion Investment?

Pfizer (NYSE: PFE) made a fortune thanks to its work in the COVID-19 market. In 2022, it became the first…

Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It

Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware…

Qatar Dietary Supplements Market Forecast Report 2025-2030 | Rising Demand for Preventive Healthcare Spurs Growth in Qatars Supplement Sector - A $70.48 Million Market by 2030

The Qatar Dietary Supplements Market is set to grow from USD 48.19 Million in 2024 to USD 70.48 Million by…

dpa-AFX ProFeed